| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |